The Nubeqa (darolutamide) regimen can be used to treat adult patients with advanced HSPC if docetaxel, a chemotherapy agent, ...
Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed ...
The company ended the first half of this year with €3.1 billion ($3.6 billion) in cash reserves, and is due to report its ...
As someone with a sound scientific background, immersed in the technical side of this work, I’ve seen firsthand how the field ...
GSK and Spero Therapeutics' oral cabapenem, tebipenem HBr, has become the first antibiotic in the class to show efficacy in a ...
AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, ...
Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...
Patient safety is a mindset that begins on day one and grows with every child. It is not confined to hospitals, it extends ...
A new report from the Institute for Clinical and Economic Review (ICER) in the US has found that the net prices of newly ...
Johnny Cheng, currently CFO of HUTCHMED, has been named acting CEO following the departure of Dr Weiguo Su due to health ...
Merck KGaA has become the third pharma company to reach an agreement with the Trump administration to cut the cost of some of ...
George Medicines' recently-approved high blood pressure therapy Widaplik could offer a desperately needed new treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results